Clinical Deterioration in Cerebral Venous Thrombosis: A Predictive Study

Capital Medical University logo

Capital Medical University

Status

Completed

Conditions

Cerebral Venous Thrombosis

Study type

Observational

Funder types

Other

Identifiers

NCT06266585
HX-B-2023090

Details and patient eligibility

About

The objective of this retrospective, prospective, multicenter cohort study is to determine the risk factors for deterioration of CVT patients after admission and establish a scoring model for risk stratification of patients. This study included two stages, the first stage was to enroll CVT patients from a single center from 2017 to 2022 for modeling, and the second stage was to enroll CVT patients from three centers in 2023 for external validation

Enrollment

273 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

* Age≥ 18 years old * Patients were diagnosed with cerebral venous thrombosis (CVT) through imaging techniques such as Computed Tomography Venography (CTV), Magnetic Resonance Venography (MRV), or Digital Subtraction Angiography (DSA) * The diagnostic algorithm for CVT conformed to the current guideline criteria

Exclusion criteria

* Patients who had performed endovascular treatment (EVT) or decompressive craniectomy (DC) before admission and those whose primary treatment was EVT or DC rather than conservative treatment after admission * Patients with severe hepatic or renal insufficiency * Patients with intracranial tumors * Patients with other cerebrovascular diseases

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems